Recent Success Combining Single Cell Sequencing with AI/Advanced Analytics
17 Jun 2020, 11:00:00 Eastern Time (ET)
Single cell sequencing has transformed our ability to discern the cellular and molecular makeup of human immune systems and tissues. The size and complexity of the data sets generated requires the application of advanced analytics and artificial intelligence to reveal the signal contained within. The marriage of scRNAseq + AI has been shown to identify rare cell populations/subtypes and provide novel insights about disease diving pathways. The ability to better understand human disease etiology has transformational impact for the biopharma industry.
In this webinar, please join the invited guest speakers as they discuss how the combination of single cell RNAseq and Artificial Intelligence can reveal causal biology and aid the understanding of disease mechanisms. The presenters will explain how the generation and analysis of this data is key to business strategy and the challenges and success they have experienced in applying these technologies together.
Speakers
Thomas W. Chittenden, PhD, DPhil, PStatChief Data Science Officer, Genuity Science
Thomas W. Chittenden, PhD, DPhil, PStatProfile Pic
Gregory Ryslik, PhD, FCAS, MAAAChief Data Officer, Celsius Therapeutics
This website stores cookies on your computer. Some of these cookies enable this website to function and some of these cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy and Privacy Policy.